NEWSROOM

Blog

BioStem Technologies Reports Record Third Quarter 2024 Revenue of $82.6 Million

BioStem Technologies Reports Record Third Quarter 2024 Revenue of $82.6 Million

Nov 12, 2024

Company reports third sequential quarter of record growth, contributing to a record total of $199.0 million in revenue for the first nine-months of 2024 Achieves third consecutive quarter of positive GAAP net income of $6.8 million or $0.42 per share. Generated Q3 2024 Adjusted EBITDA of $9.9 million Financial Results Conference Call and Webcast on Tuesday, November 12, 2024, at 4:30 pm ET POMPANO BEACH, FL, November 12, 2024 - PRISM MediaWire - BioStem Technologies, Inc. (OTC: BSEM) (the...

Lipella Pharmaceuticals Secures Extended Market Exclusivity with Issuance of U.S. Patent for Liposomal Delivery Platform

Lipella Pharmaceuticals Secures Extended Market Exclusivity with Issuance of U.S. Patent for Liposomal Delivery Platform

Nov 12, 2024

PITTSBURGH, November 12, 2024 - PRISM MediaWire - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a clinical-stage biotechnology company focused on developing innovative therapies for serious diseases with unmet medical needs, today announced that U.S. Patent No. 12,138,345 for its proprietary liposomal drug delivery platform will be officially issued by the U.S. Patent and Trademark Office (USPTO) on November 12, 2024. This patent, titled "Delivery of Agents Using Metastable Liposomes," covers...

SKYX Announces Corporate Update Call

SKYX Announces Corporate Update Call

Nov 8, 2024

Company to Provide Corporate Updates Including New Developments and Third Quarter 2024 Financial Results; Conference Call to be Held on Tuesday, November 12, 2024, at 4:30 PM Eastern Time Miami, November 8, 2024 - PRISM MediaWire - SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive smart platform technology company with over 97 issued and pending patents in the U.S. and globally, and which owns over 60 lighting and home décor websites with a mission to make homes and...

Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12

Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12

Nov 6, 2024

Conference Call and Webcast on Tuesday, November 12, 2024, at 2:00 p.m. PT / 5:00 p.m. ET IRVINE, Calif., Nov. 6, 2024 - PRISM MediaWire - Oncocyte Corp. (Nasdaq: OCX), a diagnostics technology company, announced today that the company will release its third quarter 2024 financial results on Tuesday, November 12, 2024, after U.S. market closes. The company will also host a conference call and webcast on Tuesday, November 12, 2024, at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to discuss...

American Shared Hospital Services Announces Third Quarter 2024 Earnings Conference Call

American Shared Hospital Services Announces Third Quarter 2024 Earnings Conference Call

Nov 6, 2024

Call Scheduled November 13th at 1:00 PM ET SAN FRANCISCO, November 6, 2024 - PRISM MediaWire - American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced that the Company will hold a conference call to discuss its third quarter 2024 financial results on November 13th at 1:00 pm ET / 10:00 am PT. The third quarter 2024 financial...

SKYX Announces Corporate Update Call

SKYX to be a Main Event at TheRealDeal Miami Real-Estate Forum & Developer Showcase Tomorrow November 6

Nov 5, 2024

As SKYX Continues to Enhance its Market Penetration in the US and Canada it Will Showcase its Patented Game-Changing Smart Home Platform Technologies with High-End Real-Estate Developers and Industry Professionals Miami, FL, November 5, 2024 - PRISM MediaWire - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive smart platform technology company with over 97 issued and pending patents in the U.S. and globally, and over 60 lighting and home décor websites with a...

Sono-Tek Announces Share Buyback

Sono-Tek Announces Share Buyback

Nov 4, 2024

MILTON, N.Y., November 4, 2024 - PRISM MediaWire - Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced that its Board of Directors has authorized the repurchase of up to $2.0 million of Sono-Tek’s outstanding common stock (the “Repurchase Program”). “We are pleased to announce the Repurchase Program and believe that it demonstrates our financial strength and confidence in our long-term growth strategy. With our solid...

Lipella Pharmaceuticals Secures Extended Market Exclusivity with Issuance of U.S. Patent for Liposomal Delivery Platform

Lipella Pharmaceuticals Announces 1-for-8 Reverse Stock Split

Nov 1, 2024

PITTSBURGH, PA, November 1, 2024 - PRISM MediaWire - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (the “Company,” “our” or “us”), a clinical-stage biotechnology company focused on developing innovative therapies for serious diseases with unmet medical needs, today announced that it intends to effect a 1-for-8 reverse stock split of its common stock effective as of 5:00 p.m. Eastern Time on November 7, 2024 upon the filing of a certificate of amendment to the Company’s certificate of...

SPZI: JP3E Enters $330,000,000 Commitment with Öztürk Holding, LLC and Kerogen Resources, LLC via Kerogen Resources II, LLC to Develop Unconventional Shale Assets

SPZI: JP3E Enters $330,000,000 Commitment with Öztürk Holding, LLC and Kerogen Resources, LLC via Kerogen Resources II, LLC to Develop Unconventional Shale Assets

Oct 31, 2024

NEW YORK, October 31, 2024 - PRISM MediaWire - JP 3E Holdings, Inc. (“JP3E”) formerly known as Spooz, Inc. (OTC: SPZI), provides an update on the execution of a legally binding Memorandum of Understanding (“MOU") with Kerogen Resources, LLC to form Kerogen Resources II, LLC as a subsidiary, majority owned by JP3E, for the purpose of developing unconventional onshore U.S. shale assets. A $330,000,000 cash commitment to Kerogen Resources, LLC through a Joint Venture agreement with Öztürk...

Digital Utilities Ventures Expands Dealer Network and Reports Strong Q1 Results, Setting the Stage for Continued Growth

Digital Utilities Ventures Expands Dealer Network and Reports Strong Q1 Results, Setting the Stage for Continued Growth

Oct 30, 2024

Mankato, MN, October 30, 2024 - PRISM MediaWire - Digital Utilities Ventures (OTC: DUTV) is pleased to announce the significant expansion of its sales force for its innovative modular Easy Nano Void Water Clean Up and Easy FEN Liquid Microbial Growth Systems. The Easy Nano Void Product Line now includes the “Shore Shed Model 30” that individual Lake Shore Owners can place next to shorelines. The technology utilizes no harmful chemicals and only trillions of tiny oxygen bubbles to quickly clean...

HUB Security to Present at the 2024 ThinkEquity Conference

HUB Security to Present at the 2024 ThinkEquity Conference

Oct 30, 2024

Tel Aviv, Israel, October 30, 2024 - PRISM MediaWire - HUB Cyber Security Ltd. (NASDAQ: HUBC) ("HUB Security" or the "Company"), a leading provider of cybersecurity solutions and advanced data fabric, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other industry professionals to highlight groundbreaking innovations and...

Holder Resources Inc. to Present at the 2024 ThinkEquity Conference

Holder Resources Inc. to Present at the 2024 ThinkEquity Conference

Oct 29, 2024

New York City, New York, Oct. 29, 2024 - PRISM MediaWire - Holder Resources Inc. (“HRI” or “the Company”), a natural resource company with operations in Guyana South America, the fastest growing economy globally, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other industry professionals to highlight groundbreaking...

United States Antimony Corporation to Present at the 2024 ThinkEquity Conference

United States Antimony Corporation to Present at the 2024 ThinkEquity Conference

Oct 29, 2024

Thompson Falls, Montana, October 29, 2024 - PRISM MediaWire - United States Antimony Corporation (“USAC” or the “Company”), (NYSE: UAMY), today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other industry professionals to highlight groundbreaking innovations and financial strategies. Gary C. Evans, Chairman and co-CEO, will...

SPZI: JP3E Enters $330,000,000 Commitment with Öztürk Holding, LLC and Kerogen Resources, LLC via Kerogen Resources II, LLC to Develop Unconventional Shale Assets

SPZI: JP 3E Holdings, Inc. (OTC: SPZI) Prepares for First Gold Shipment

Oct 29, 2024

NEW YORK, October 29, 2024 - PRISM MediaWire - JP 3E Holdings, Inc. (OTC: SPZI) is pleased to announce a new partnership for sourcing and exporting minerals and precious metals, including rare earths, copper, zinc, and cobalt, from the African continent to global buyers. This collaboration marks a significant milestone in JP3E’s expansion of its global trading business, supported by Bloxcross’ proprietary trade finance platform. The first gold shipment under this partnership is scheduled for...

Lipella Pharmaceuticals to Present at 2024 Spartan Capital Investor Conference

Lipella Pharmaceuticals to Present at 2024 Spartan Capital Investor Conference

Oct 29, 2024

PITTSBURGH, Pa., Oct. 29, 2024 – PRISM MediaWire - Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on addressing serious diseases with significant unmet needs, today announced that CEO Jonathan Kaufman, PhD will be presenting at the 2024 Spartan Capital Investor Conference that is being held on November 4, 2024, at the Pierre Hotel in New York. Event: Lipella Presentation - 2024 Spartan Capital Investor Conference Date:...

AmpliTech Group’s AGTGSS Division Releases New Portable 5G Networks In A Box (NIB) For Military, First Responders, And On-Demand Commercial Events

AmpliTech Group’s AGTGSS Division Releases New Portable 5G Networks In A Box (NIB) For Military, First Responders, And On-Demand Commercial Events

Oct 29, 2024

New Products Include Backpack, Rolling Suitcase and Vehicle Mounted NIB’s Hauppauge, NY, October 29, 2024 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced the release of its...

Sono-Tek Announces Participation at The Spartan Capital Investor Conference

Sono-Tek Announces Participation at The Spartan Capital Investor Conference

Oct 29, 2024

Premier Event to Showcase Growth Companies and Foster High-Level Investor Engagement MILTON, N.Y., October 29, 2024 - PRISM MediaWire - Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced its participation in Spartan Capital Securities, LLC's inaugural investor conference on November 4th at the Pierre Hotel in New York. Steve Harshbarger, CEO & President of Sono-Tek will provide a formal presentation to investor...

BioStem Technologies Initiates Nationwide Launch of Vendaje AC® with Venture Medical Following Established Reimbursement in All Medicare Administrative Contractor (MAC) Regions

BioStem Technologies Initiates Nationwide Launch of Vendaje AC® with Venture Medical Following Established Reimbursement in All Medicare Administrative Contractor (MAC) Regions

Oct 29, 2024

The pricing announcement from the Center for Medicare Services became effective on October 1, 2024, and allows BioStem to begin marketing initiatives with Venture Medical POMPANO BEACH, Fla., October 29, 2024 - PRISM MediaWire - BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, announces it will initiate a nationwide launch of Vendaje AC® with Venture Medical,...

BioStem Technologies Initiates Nationwide Launch of Vendaje AC® with Venture Medical Following Established Reimbursement in All Medicare Administrative Contractor (MAC) Regions

BioStem Technologies to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

Oct 28, 2024

Conference Call and Webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., October 28, 2024 - PRISM MediaWire - BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, announces that it will release its Third quarter 2024 financial results on Tuesday, November 12, 2024, and host a conference call and webcast at 4:30 PM ET to discuss the results. The webcast will...

IBC Advanced Alloys to Present on October 30 at the 2024 ThinkEquity Conference

IBC Advanced Alloys to Present on October 30 at the 2024 ThinkEquity Conference

Oct 28, 2024

Presentation to be Webcast Live at 11:30 a.m. Eastern New York, New York, October 28, 2024 - PRISM MediaWire - IBC Advanced Alloys (“IBC” or the “Company”) (TSX-V: IB; OTCQB: IAALF), a leading U.S. producer of copper alloy products to defense and commercial markets, announces that it will be participating in the ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other...

Immunophotonics to Present at the 2024 ThinkEquity Conference

Immunophotonics to Present at the 2024 ThinkEquity Conference

Oct 28, 2024

St. Louis, Missouri, October 28, 2024 - PRISM MediaWire - Immunophotonics, Inc. a clinical-stage biotech company focused on the discovery and development of novel immune-activating drugs, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other industry professionals to highlight groundbreaking innovations and financial...

Zoomcar to Present at the 2024 ThinkEquity Conference

Zoomcar to Present at the 2024 ThinkEquity Conference

Oct 28, 2024

Bangalore, India, October 28, 2024 - PRISM MediaWire - Zoomcar Holdings, Inc. (“Zoomcar” or the “Company”) (Nasdaq: ZCAR), the Nasdaq-listed leading marketplace for self-drive car sharing, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other industry professionals to highlight groundbreaking innovations and financial...

Ethical Web AI announces our new Chief Executive Officer – Manfred Ebensberger, with a shareholder update

Ethical Web AI announces our new Chief Executive Officer – Manfred Ebensberger, with a shareholder update

Oct 25, 2024

NEW YORK, October 25, 2024 - PRISM MediaWire - Bubblr Inc., d/b/a Ethical Web AI (OTC: BBLR) - a frontrunner in ethical technology determined to revolutionize the digital domain, has announced its new CEO, Manfred Ebensberger. Before joining Bubblr, Mr. Ebensberger held senior roles in European investment firms, serving as Managing Director and Asset Manager for Ultra-High-Net-Worth Individuals (UHNWIs). He also served as CEO of a luxury Italian fashion brand in New York. Earlier in his...

XTI Aerospace to Present at the ThinkEquity Conference

XTI Aerospace to Present at the ThinkEquity Conference

Oct 24, 2024

ENGLEWOOD, Colo., October 24, 2024 - PRISM MediaWire - XTI Aerospace, Inc. (NASDAQ: XTIA) ("XTI Aerospace" or the "Company") today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. Past ThinkEquity conferences have featured over 70 company presentations, 700+ attendees, and 500+ one-on-one meetings, providing a valuable platform for companies and investors to connect. Scott Pomeroy, Chief Executive Officer of...

NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference

NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference

Oct 24, 2024

EDEN PRAIRIE, Minn., October 24, 2024 - PRISM MediaWire - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate...

Sidus Space to Present at the 2024 ThinkEquity Conference

Sidus Space to Present at the 2024 ThinkEquity Conference

Oct 24, 2024

CAPE CANAVERAL, FL, October 24, 2024 - PRISM MediaWire - Sidus Space (NASDAQ: SIDU) (the “Company” or “Sidus”), an innovative, agile space mission enabler, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other industry professionals to highlight groundbreaking innovations and financial strategies. Carol Craig, CEO, will...

Soligenix, Inc. to Present at the 2024 ThinkEquity Conference

Soligenix, Inc. to Present at the 2024 ThinkEquity Conference

Oct 24, 2024

Princeton, NJ, October 24, 2024 - PRISM MediaWire - Soligenix, Inc. (Nasdaq: SNGX) (“Soligenix” or the “Company”) a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other...

BranchOut Food Shareholder Update: Projects $15M Run Rate and Positive Cash Flow for Q1 2025 Amid Surge in New Orders as Peru Factory Opens

BranchOut Food Shareholder Update: Projects $15M Run Rate and Positive Cash Flow for Q1 2025 Amid Surge in New Orders as Peru Factory Opens

Oct 24, 2024

BranchOut Peru Facility Now Operational, Driving Profitability Through High-Margin Production Key Highlights: Projecting $3.8M in Q1 revenue, with strong growth throughout the year Inflecting to Positive Cash Flow Beginning in Q1 2025 Peru Facility Now Operational, Producing Initial Orders and Capturing High Margins Nation’s Largest Warehouse Club Reorders $1.7M After Strong Per-Store Sales, Expanding Regions and Tripling SKUs. Planning 2025 Sales Strategy for the Ingredient Channel; in talks...

Adial Pharmaceuticals to Present at the 2024 ThinkEquity Conference

Adial Pharmaceuticals to Present at the 2024 ThinkEquity Conference

Oct 23, 2024

Glen Allen, VA, October 23, 2024 - PRISM MediaWire - Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate clients, and other...

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and HOPE Therapeutics, Inc. Announce Participation at the ThinkEquity Conference October 30, 2024

NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) and HOPE Therapeutics, Inc. Announce Participation at the ThinkEquity Conference October 30, 2024

Oct 23, 2024

MIAMI, FL., October 23, 2024 – PRISM MediaWire - NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, (“NRx,” the “Company”) and HOPE Therapeutics, Inc., a medical and technology driven company and wholly-owned subsidiary of NRx, today announced they will be featured as a participating in the ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel in New York. The ThinkEquity Conference gathers institutional investors, corporate...